Congressional leaders re-introduce legislation to address the high cost of prescription drugs
April 22, 2021
This week, Congressional leaders from both parties re-introduced legislation from the previous Congress that would address the high cost of prescription drugs. On Wednesday, April 21, Republican leaders introduced the Lower Costs, More Cure Act (H.R. 19)
and on Thursday, April 22, Democratic leaders introduced the Elijah E. Cummings Lower Drug Costs Now Act (H.R. 3)
The Society is glad that Congressional leaders are turning their attention to addressing the high cost of prescription drugs and will be evaluating these proposals to ensure they take meaningful actions to lower the cost of medications for people with MS. We look forward to working with Congressional leaders from both parties and urge Congress to pass comprehensive legislation to address the high cost of medications so that people have access to the therapies they need to live their best lives.
about the National MS Society’s access to MS medications recommendations, latest survey data, and to hear the stories of people affected by access to MS medications.
The National MS Society, founded in 1946, funds cutting-edge research, drives change through advocacy, and provides programs and services to help people affected by MS live their best lives. Connect to learn more and get involved: nationalMSsociety.org, Facebook, Twitter, Instagram, YouTube or 800-344-4867.